XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.24.3

COMPUTATION OF LOSS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2024 | Dec. 31, 2023
Loss per Common Share |  |
COMPUTATION OF LOSS PER SHARE | NOTE 12 - COMPUTATION OF LOSS PER SHARE Computation of basic and dilutive loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows: SCHEDULE OF BASIC AND DILUTIVE LOSS PER SHARE
|  | For the three months ended September 30, 2024 |  |  | For the three months ended September 30, 2023 |  |  | For the nine months ended September 30, 2024 |  |  | For the nine months ended September 30, 2023 |
Net income (loss) available to common stockholders |  | $ | 1,195,000 |  |  | $ | 97,000 |  |  | $ | (7,292,000 | ) |  | $ | (5,348,000 | )
Weighted-average common shares outstanding |  |  | 9,095,504 |  |  |  | 4,220,259 |  |  |  | 7,341,204 |  |  |  | 3,726,259 |
Basic and diluted income (loss) per share |  | $ | 0.13 |  |  | $ | 0.03 |  |  | $ | (0.99 | ) |  | $ | (1.44 | )
Basic net loss per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options and the proceeds thereof were used to purchase shares of the Company’s common stock at the average market price during the period using the treasury stock method. For the three and nine months ended September 30, 2024 and 2023, options to purchase 98,178 and 91,261 shares of common stock, respectively and options to purchase 902,113 common stock warrants for both September 30, 2024 and 2023 were excluded in the calculation of diluted net loss per share as the result would have been anti-dilutive. | NOTE 10 - COMPUTATION OF (LOSS) EARNINGS PER SHARE COMPUTATION OF LOSS PER SHARE Computation of dilutive shares for the nine months ended December 31, 2023 and fiscal years ended March 31, 2023 and 2022 are as follows: SCHEDULE OF BASIC AND DILUTIVE SHARES
|  | Nine months ended December 31, 2023 |  |  | Fiscal year ended March 31, 2023 |  |  | Fiscal year ended March 31, 2022 |
Basic weighted average common shares outstanding |  |  | 4,864,540 |  |  |  | 2,811,872 |  |  |  | 1,614,506 |
Effect of dilutive stock options |  |  | - |  |  |  | - |  |  |  | 8,891 |
Diluted weighted average of common shares outstanding |  |  | 4,864,540 |  |  |  | 2,811,872 |  |  |  | 1,623,397 |
Basic net (loss) income per share is based on the weighted average number of shares of common stock outstanding during the period. Diluted net (loss) income per share reflects the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options and the proceeds thereof were used to purchase shares of the Company’s common stock at the average market price during the period using the treasury stock method. For the nine months ended December 31, 2023, options to purchase 113,761 shares of common stock and 902,113 common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive. For the fiscal year ended March 31, 2023, options to purchase 53,675 shares of common stock and 902,113 common stock warrants were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive. For the fiscal year ended March 31, 2022, pre-funded warrants to purchase 561,111 shares of common stock were included in basic weighted average shares outstanding as deemed outstanding. Options to purchase 8,891 shares of common stock were included in the calculation of diluted net income per share. For the fiscal year ended March 31, 2022, options and warrants to purchase approximately 56,000 shares of common stock were excluded in the calculation of diluted net (loss) income per share as the result would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration